1. Home
  2. BRTX vs BRN Comparison

BRTX vs BRN Comparison

Compare BRTX & BRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRTX
  • BRN
  • Stock Information
  • Founded
  • BRTX 1997
  • BRN 1956
  • Country
  • BRTX United States
  • BRN United States
  • Employees
  • BRTX N/A
  • BRN N/A
  • Industry
  • BRTX Managed Health Care
  • BRN Oil & Gas Production
  • Sector
  • BRTX Health Care
  • BRN Energy
  • Exchange
  • BRTX Nasdaq
  • BRN Nasdaq
  • Market Cap
  • BRTX 12.5M
  • BRN 11.4M
  • IPO Year
  • BRTX N/A
  • BRN N/A
  • Fundamental
  • Price
  • BRTX $1.84
  • BRN $1.14
  • Analyst Decision
  • BRTX
  • BRN
  • Analyst Count
  • BRTX 0
  • BRN 0
  • Target Price
  • BRTX N/A
  • BRN N/A
  • AVG Volume (30 Days)
  • BRTX 88.0K
  • BRN 21.7K
  • Earning Date
  • BRTX 08-12-2025
  • BRN 08-13-2025
  • Dividend Yield
  • BRTX N/A
  • BRN N/A
  • EPS Growth
  • BRTX N/A
  • BRN N/A
  • EPS
  • BRTX N/A
  • BRN N/A
  • Revenue
  • BRTX $605,200.00
  • BRN $18,073,000.00
  • Revenue This Year
  • BRTX $232.67
  • BRN N/A
  • Revenue Next Year
  • BRTX $52.92
  • BRN N/A
  • P/E Ratio
  • BRTX N/A
  • BRN N/A
  • Revenue Growth
  • BRTX 247.62
  • BRN N/A
  • 52 Week Low
  • BRTX $1.21
  • BRN $1.08
  • 52 Week High
  • BRTX $2.55
  • BRN $2.53
  • Technical
  • Relative Strength Index (RSI)
  • BRTX 72.78
  • BRN 47.18
  • Support Level
  • BRTX $1.51
  • BRN $1.12
  • Resistance Level
  • BRTX $1.56
  • BRN $1.29
  • Average True Range (ATR)
  • BRTX 0.08
  • BRN 0.05
  • MACD
  • BRTX 0.04
  • BRN 0.01
  • Stochastic Oscillator
  • BRTX 89.91
  • BRN 21.05

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

About BRN Barnwell Industries Inc.

Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.

Share on Social Networks: